{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:37:23Z","timestamp":1769161043415,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.oret.2017.09.021","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T14:16:56Z","timestamp":1510841816000},"page":"623-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Supplemental Laser for Eyes Treated with Bevacizumab Monotherapy in Severe Retinopathy of Prematurity"],"prefix":"10.1016","volume":"2","author":[{"given":"Manish","family":"Tandon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Y.","family":"Vishal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyush","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu P.","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2017.09.021_bib1","first-page":"26","article-title":"Childhood blindness","volume":"3","author":"Stenkuller","year":"1999","journal-title":"J\u00a0AAPOS"},{"issue":"Suppl 2","key":"10.1016\/j.oret.2017.09.021_bib2","first-page":"S80","article-title":"Can we stop the current epidemic of blindness from Retinopathy of Prematurity?","volume":"53","author":"Dutta","year":"2016","journal-title":"Indian Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.oret.2017.09.021_bib3","first-page":"S123","article-title":"Retinopathy of Prematurity: AIIMS, New Delhi experience","volume":"53","author":"Sivanandan","year":"2016","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.oret.2017.09.021_bib4","first-page":"211","article-title":"Incidence and risk factors of retinopathy of prematurity in a tertiary care new born unit in New Delhi","volume":"9","author":"Maheshwari","year":"1996","journal-title":"Natl Med J India"},{"key":"10.1016\/j.oret.2017.09.021_bib5","first-page":"187","article-title":"Magnitude of the problem of Retinopathy of Prematurity. Experience in a large maternity unit with a medium size level-3 nursery","volume":"49","author":"Varughese","year":"2001","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s12098-012-0707-y","article-title":"Retinopathy of prematurity in a rural neonatal intensive care unit in South India-a prospective study","volume":"79","author":"Hungi","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.oret.2017.09.021_bib7","first-page":"219","article-title":"Retinopathy of prematurity in a tertiary care center\u2013incidence, risk factors and outcome","volume":"46","author":"Chaudhari","year":"2009","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.oret.2017.09.021_bib8","first-page":"123","article-title":"The incidence of retinopathy of prematurity in a neonatal care unit","volume":"43","author":"Charan","year":"1995","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib9","first-page":"50","article-title":"Retinopathy of prematurity. A study","volume":"43","author":"Gopal","year":"1995","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib10","first-page":"89","article-title":"Programme planning and screening strategy in retinopathy of prematurity","volume":"51","author":"Jalali","year":"2003","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0301-4738.126178","article-title":"The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting","volume":"62","author":"Vinekar","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0161-6420(91)32247-4","article-title":"Laser photocoagulation for stage 3+ retinopathy of prematurity","volume":"98","author":"McNamara","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2017.09.021_bib13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archopht.119.8.1110","article-title":"Multicentre trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajo.2010.10.007","article-title":"Outcomes of a protocol based management for zone I retinopathy of prematurity. The Indian twin cities ROP screening program report number 2","volume":"151","author":"Jalali","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/IAE.0b013e318169faee","article-title":"Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes","volume":"28","author":"Axer-Siegel","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.oret.2017.09.021_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3928\/01913913-20081101-02","article-title":"Structural sequelae and refractive outcome after successful laser treatment for threshold retinopathy of prematurity","volume":"45","author":"Dhawan","year":"2008","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.oret.2017.09.021_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2017.09.021_bib18","first-page":"6","article-title":"Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity","volume":"14","author":"Law","year":"2010","journal-title":"JAAPOS"},{"key":"10.1016\/j.oret.2017.09.021_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3928\/23258160-20160229-12","article-title":"Very late reactivation of retinopathy of prematurity after monotherapy with intravitreal bevacizumab","volume":"47","author":"Snyder","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2017.09.021_bib20","first-page":"282","article-title":"Compliance with outpatient follow-up recommendations for infants at risk for retinopathy of prematurity","volume":"4","author":"Aprahamian","year":"2000","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.oret.2017.09.021_bib21","series-title":"National Neonatology Forum, Evidence Based Clinical Practice Guidelines, Chapter on Retinopathy of Prematurity, NNF India, Guidelines","first-page":"253","author":"Pejaver","year":"2010"},{"key":"10.1016\/j.oret.2017.09.021_bib22","first-page":"124","article-title":"Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age","volume":"17","author":"Quinn","year":"2013","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.oret.2017.09.021_bib23","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/eye.2014.172","article-title":"Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity:2-year outcomes","volume":"28","author":"Chen","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2017.09.021_bib24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ajo.2013.01.014","article-title":"Intravitreal bevacizumab for retinopathy of prematurity: refractive error results","volume":"155","author":"Harder","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bjophthalmol-2016-308828","article-title":"The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review","volume":"101","author":"Kandasamy","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","article-title":"Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib27","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1651-2227.2011.02445.x","article-title":"On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review","volume":"100","author":"H\u00e5rd","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.oret.2017.09.021_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2017.09.021_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib30","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/IAE.0000000000000535","article-title":"Plasma concentrations of vascular endothelial growth factor in retinopathy of prematurity after intravitreal bevacizumab injection","volume":"35","author":"Hong","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2017.09.021_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000252970","article-title":"Pulmonary vascular endothelial growth factor expression and disaturated phospholipid content in a chicken model of hypoxia-induced fetal growth restriction","volume":"97","author":"Been","year":"2010","journal-title":"Neonatology"},{"issue":"2\u00a0Pt\u00a02","key":"10.1016\/j.oret.2017.09.021_bib32","first-page":"F240","article-title":"Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney","volume":"268","author":"Simon","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.oret.2017.09.021_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000101344","article-title":"Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity","volume":"91","author":"Thebaud","year":"2007","journal-title":"Neonatology"},{"key":"10.1016\/j.oret.2017.09.021_bib34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajo.2005.12.016","article-title":"Modification of screening criteria for retinopathy of prematurity in India and other middle-income countries","volume":"141","author":"Jalali","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/bjo.2005.078063","article-title":"Characteristics of severe retinopathy of prematurity patients in China: a repeat of the first epidemic?","volume":"90","author":"Chen","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10384-003-0014-2","article-title":"Applicability of American and British criteria for screening of the retinopathy of prematurity in Thailand","volume":"48","author":"Trinavarat","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12098-009-0175-1","article-title":"Severe retinopathy of prematurity in big babies in India: history repeating itself?","volume":"76","author":"Shah","year":"2009","journal-title":"Indian J Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.oret.2017.09.021_bib38","first-page":"S151","article-title":"Improving follow-up of infants during retinopathy of prematurity screening in rural areas","volume":"53","author":"Vinekar","year":"2016","journal-title":"Indian Paediatr"},{"key":"10.1016\/j.oret.2017.09.021_bib39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2014-3526","article-title":"Cognition and brain structure following early childhood surgery with anesthesia","volume":"136","author":"Backeljauw","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.oret.2017.09.021_bib40","doi-asserted-by":"crossref","first-page":"e85760","DOI":"10.1371\/journal.pone.0085760","article-title":"Current clinical evidence on the effect of general anesthesia on neurodevelopment in children: an updated systematic review with meta-regression","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2017.09.021_bib41","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/IAE.0b013e31820d3f70","article-title":"Management of avascular peripheral retina in older prematurely born infants","volume":"31","author":"Ho","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.oret.2017.09.021_bib42","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/IAE.0b013e318159ec91","article-title":"Ischemic retinopathy and neovascular proliferation secondary to shaken baby syndrome","volume":"28","author":"Caputo","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.oret.2017.09.021_bib43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2011.04.028","article-title":"Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice","volume":"118","author":"Moshfeghi","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2017.09.021_bib44","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.ophtha.2016.06.054","article-title":"Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system","volume":"123","author":"Good","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2017.09.021_bib45","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00417-014-2867-0","article-title":"Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity - 27 month follow-up results from Turkey","volume":"253","author":"Yetik","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib46","first-page":"102582","article-title":"Outcomes and prognostic factors of intravitreal bevacizumab monotherapy in zone i stage 3+ and aggressive posterior retinopathy of prematurity","volume":"2015","author":"Nicoara","year":"2015","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.oret.2017.09.021_bib47","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.12659\/MSM.897095","article-title":"Regression rates following the treatment of aggressive posterior retinopathy of prematurity with bevacizumab versus laser: 8-year retrospective analysis","volume":"22","author":"Nicoara","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.oret.2017.09.021_bib48","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy","volume":"123","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653017302749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653017302749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:23:59Z","timestamp":1762853039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653017302749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2468653017302749"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2017.09.021","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supplemental Laser for Eyes Treated with Bevacizumab Monotherapy in Severe Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2017.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}